Retatrutide 10mg
Code: RT10 · Category: Metabolic & Weight Management · Price: ₹10,000
Summary
Triple-receptor agonist peptide (GIP / GLP-1 / Glucagon) — 10 mg lyophilized, ≥98% HPLC purity.
Full description
Retatrutide 10 mg is a synthetic triple-agonist peptide under investigation in metabolic research. Designed to engage GIP, GLP-1, and glucagon receptors simultaneously, it has been studied in preclinical models of energy expenditure, glucose handling, and body-composition research.
Research Profile
- Triple-agonist activity across GIP, GLP-1, and glucagon receptors
- Studied in metabolic and energy-balance research models
- Lyophilized format for stable, long-term storage
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: Retatrutide (LY3437943)
- Dosage: 10 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Specifications
| Compound | Retatrutide (LY3437943) |
|---|---|
| Class | Triple-agonist peptide (GIP / GLP-1 / Glucagon receptor) |
| Dosage | 10 mg per vial |
| Purity | ≥ 98% (HPLC) |
| Form | Lyophilized powder |
| Appearance | White to off-white cake |
| Storage | Store lyophilized at 2–8 °C. Reconstituted: –20 °C, use within 30 days. |
| Reconstitution | Bacteriostatic water (sold separately) |
| Research Use | Investigational compound for laboratory research only. |